xamoterol has been researched along with sulbactam in 3 studies
Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (sulbactam) | Trials (sulbactam) | Recent Studies (post-2010) (sulbactam) |
---|---|---|---|---|---|
269 | 80 | 17 | 1,844 | 297 | 488 |
Protein | Taxonomy | xamoterol (IC50) | sulbactam (IC50) |
---|---|---|---|
Beta-lactamase | Escherichia coli | 6.2 | |
Beta-lactamase | Shouchella clausii | 0.075 | |
Beta-lactamase | Pseudomonas aeruginosa | 0.37 | |
Beta-lactamase | Pseudomonas aeruginosa | 3 | |
Beta-lactamase | Aeromonas allosaccharophila | 4 | |
Beta-lactamase | Staphylococcus aureus | 6.5 | |
Beta-lactamase | Enterobacter cloacae | 1.4 | |
Beta-lactamase TEM | Escherichia coli | 4.3 | |
Beta-lactamase | Acinetobacter pittii | 1.12 | |
Beta-lactamase | Acinetobacter pittii | 7.758 | |
Beta-lactamase | Pseudomonas aeruginosa | 3 | |
Beta-lactamase | Escherichia coli | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
3 other study(ies) available for xamoterol and sulbactam
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |